Digestive tract pathology
PRINCIPAL INVESTIGATORS
- Josep Maria Botargues Boté
- Marta Climent Agustín
- Jose Ricardo Frago Montanuy
- Jordi Guardiola Capón
- Alexandra Ruiz Cerulla
CLINICAL RESEARCHERS
- Ana Maria Berrozpe López
- Carla Bettonica Larrañaga
- Ana Roberta Galvez Saldaña
- Thomas Otto Golda
- Jaime Lopez Borao
- Zoilo Madrazo González
- Kristel Mils Julià
- Loris Trenti
SCIENTIFIC SUPPORT
- Oriana Carolina Barrios Cormenzanza
Translational Medicine
Digestive system, diagnostics, pharmacogenetics, care support and clinical prevention
Scientific production
24
PAPERS
Average IF: 5,70
3
LED PAPERS
Average IF: 6,30
10 PUBLICATIONS IN FIRST DECILE
17 PUBLICATIONS IN FIRST QUARTILE
15 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Serra Aracil,X;Pericay,C;Cidoncha,A;Badia Closa,J;Golda,T;Kreisler,E;Hernández,P et al, Chemoradiotherapy and Local Excision vs Total Mesorectal Excision in T2-T3ab, N0, M0 Rectal Cancer: The TAUTEM Randomized Clinical Trial., JAMA Surg, 2025;160(7):783-793, doi:10.1001/jamasurg.2025.1398
- Dajti,E;Frazzoni,L;Castellet Farrús,S;Guardiola,J;Sinagra,E;Anderloni,A;Ferrara,F et al, In-hospital mortality in patients with lower gastrointestinal bleeding: development and validation of a prediction score., Endoscopy, 2025;57(8):839-848, doi:10.1055/a-2541-2312
- Palomino,L;Rodríguez Belvís,MV;Casanova,MJ;Leo Carnerero,E;Suarez,CC;Rivero,M;Calvo,M et al, Psychomotor development in infants following maternal exposure to biologics: Results from the DUMBO registry., Clin Gastroenterol Hepatol, 2025;doi:10.1016/j.cgh.2025.05.012
- Serra Aracil,X;Hidalgo,J;Perucho,NL;Montesinos,CS;Diaz,CG;Figueras,RV;Rivilla,SD et al, Multicentre, prospective, randomized controlled non-inferiority trial of bladder catheter management in short-duration, minimally invasive colon surgery (The Vesicalcath I-Study)., Int J Surg, 2025;111(11):8088-8098, doi:10.1097/JS9.0000000000002962
- Abbassi,F;Ramser,M;Pfister,M;Staiger,RD;Kim,SJ;Park,J;van de Laar,BCT et al, Global benchmarks for minimally invasive right hemicolectomy for cancer, Br J Surg, 2025;112(12):doi:10.1093/bjs/znaf259,
Research highlights
PROJECTS
3 Ongoing competitive projects
4 Started clinical trials
10 Ongoing clinical trials
PUBLISHED WORKS
2 Clinical guidelines
INNOVATION
1 License
1 Patent
Selected projects
- Estudio prospectivo y multicéntrico sobre factores clínico-biológicos predictivos de Diverticulitis CRÓnica de colon (DICRO). Hospital Universitario de Bellvitge. Budget: 19.450€. 2022-2026. PI: MARTA CLIMENT AGUSTÍN.
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF VE303 FOR PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: THE RESTORATIVE303 STUDY. Vedanta Biosciences, Inc. Budget: 22.771,41€. 2025- . PI: JORDI GUARDIOLA CAPÓN.
- ESTUDIO PROSPECTIVO, POST-COMERCIALIZACIÓN, NO INTERVENCIONISTA PARA EVALUAR LA EFECTIVIDAD DE RISANKIZUMAB EN PRÁCTICA CLÍNICA REAL EN LA ENFERMEDAD DE CROHN (APPRISE) (A PROSPECTIVE, POST-MARKETING, NONINTERVENTIONAL STUDY OF RISANKIZUMAB EVALUATING REAL-WORLD CLINICAL EFFECTIVENESS IN CROHN’S DISEASE, APPRISE). AbbVie Spain, S.L.U. Budget: 11.687,5€. 2024- . PI: JORDI GUARDIOLA CAPÓN.
- PROSPECTIVE REAL-WORLD STUDY OF UPADACITINIB IN ULCERATIVE COLITIS (PROFUNDUS). AbbVie Spain, S.L.U. Budget: 9.000€. 2024- . PI: JORDI GUARDIOLA CAPÓN.
- DESESCALADA DEL TRATAMIENTO ANTI-TNF EN ADOLESCENTES Y ADULTOS JÓVENES CON EII CON UN CONTROL ESTRICTO DE LOS NIVELES DE CALPROTECTINA FECAL Y DE LOS NIVELES DE CONCENTRACIÓN MÍNIMOS. University Medical Center Groningen. Budget: 7.500€. 2023- . PI: JORDI GUARDIOLA CAPÓN.